Product Code: ETC13148160 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Point of Care Infectious Disease Diagnostics Market was valued at USD 2.8 Billion in 2024 and is expected to reach USD 4.1 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The Global Point of Care Infectious Disease Diagnostics Market is witnessing significant growth driven by the increasing prevalence of infectious diseases worldwide and the need for rapid and accurate diagnostic solutions. The market is characterized by the rising demand for decentralized testing to enable timely treatment decisions, particularly in remote or resource-limited settings. Technological advancements in point-of-care testing devices, such as molecular diagnostics and immunoassays, are further fueling market growth. Key players in the market are focusing on developing user-friendly, portable, and cost-effective diagnostic tools to cater to the growing demand. The market is expected to continue expanding as healthcare systems strive to combat infectious diseases effectively through early detection and prompt intervention, driving adoption of point-of-care infectious disease diagnostics globally.
The Global Point of Care Infectious Disease Diagnostics Market is seeing significant growth driven by the increasing prevalence of infectious diseases worldwide and the need for rapid diagnostic testing. Key trends include the development of advanced technologies such as molecular diagnostics and immunoassays for quicker and more accurate results, as well as the rising demand for point-of-care testing in remote and underserved areas. Opportunities lie in the expansion of product portfolios by key players, strategic partnerships, and collaborations to enhance market presence, and the adoption of innovative diagnostic solutions for emerging infectious diseases. The market is also witnessing a shift towards decentralized healthcare settings, driving the demand for portable and easy-to-use diagnostic devices for infectious diseases. Overall, the market is poised for continued growth and innovation in the coming years.
The Global Point of Care Infectious Disease Diagnostics Market faces several challenges, including the need for accurate and reliable testing methods, particularly in resource-limited settings. Ensuring the quality and consistency of results obtained at the point of care is crucial for effective disease management and treatment decisions. Additionally, the accessibility and affordability of point-of-care diagnostic tests remain significant hurdles, especially in developing countries where healthcare infrastructure may be limited. Regulatory requirements and the need for proper training of healthcare professionals to perform these tests accurately also present challenges. Furthermore, the rapid evolution of infectious diseases and the emergence of new pathogens require constant innovation and adaptation in point-of-care diagnostics to effectively combat these threats.
The Global Point of Care Infectious Disease Diagnostics Market is primarily driven by the increasing prevalence of infectious diseases worldwide, leading to a growing demand for rapid and accurate diagnostic solutions at the point of care. The need for timely diagnosis and treatment to prevent the spread of infections, especially in resource-limited settings, is a key factor propelling market growth. Additionally, advancements in technology, such as the development of portable and user-friendly diagnostic devices, are enhancing the accessibility and efficiency of point-of-care testing. Furthermore, the rising focus on personalized medicine and the shift towards decentralized healthcare delivery models are also contributing to the expansion of the market for point-of-care infectious disease diagnostics. Overall, the market is expected to continue to grow due to these factors driving demand for convenient and rapid diagnostic solutions.
Government policies related to the Global Point of Care Infectious Disease Diagnostics Market typically focus on regulations for the development, approval, and distribution of diagnostic tests. Regulatory bodies such as the FDA in the United States and the European Medicines Agency in Europe play a crucial role in ensuring the safety and efficacy of these tests. Policies may include requirements for clinical validation studies, quality control standards, and reporting of test results. Additionally, governments may provide funding or incentives to support research and development in this area, particularly for tests targeting high-priority infectious diseases. Overall, government policies aim to facilitate the availability of accurate and timely diagnostic tools to improve public health outcomes and control the spread of infectious diseases globally.
The Global Point of Care Infectious Disease Diagnostics Market is expected to witness significant growth in the coming years due to the increasing prevalence of infectious diseases worldwide, the rising demand for rapid diagnostic testing, and the advancements in technology for point-of-care testing devices. The market is projected to expand as healthcare facilities strive to improve patient outcomes by enabling quicker and more accurate diagnosis of infectious diseases at the point of care. Additionally, the ongoing COVID-19 pandemic has highlighted the importance of rapid and decentralized testing, further driving the adoption of point-of-care infectious disease diagnostics. Market players are likely to focus on developing innovative testing solutions that offer high sensitivity and specificity, along with user-friendly interfaces, to cater to the growing demand for rapid and reliable diagnostic tools in diverse healthcare settings.
The Global Point of Care Infectious Disease Diagnostics Market is expected to witness significant growth across all regions. In Asia, rapid urbanization and increasing healthcare expenditure are driving market expansion. North America is leading in terms of market share due to high adoption of advanced diagnostic technologies. Europe is experiencing steady growth with a focus on improving healthcare infrastructure. The Middle East and Africa region is witnessing a rise in infectious diseases, leading to an increased demand for point-of-care diagnostics. Latin America is also showing promising growth potential driven by government initiatives to improve healthcare access in remote areas. Overall, the market in all regions is expected to be influenced by factors such as technological advancements, rising prevalence of infectious diseases, and increasing awareness about early disease detection.
Global Point of Care Infectious Disease Diagnostics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Point of Care Infectious Disease Diagnostics Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Global Point of Care Infectious Disease Diagnostics Market - Industry Life Cycle |
3.4 Global Point of Care Infectious Disease Diagnostics Market - Porter's Five Forces |
3.5 Global Point of Care Infectious Disease Diagnostics Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Point of Care Infectious Disease Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Global Point of Care Infectious Disease Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Point of Care Infectious Disease Diagnostics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Global Point of Care Infectious Disease Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Point of Care Infectious Disease Diagnostics Market Trends |
6 Global Point of Care Infectious Disease Diagnostics Market, 2021 - 2031 |
6.1 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Lateral Flow, 2021 - 2031 |
6.1.3 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Agglutination Assays, 2021 - 2031 |
6.1.4 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Flow-Through, 2021 - 2031 |
6.1.5 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Solid Phase, 2021 - 2031 |
6.2 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By HIV, 2021 - 2031 |
6.2.3 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Tropical Disease, 2021 - 2031 |
6.2.4 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Liver Disease, 2021 - 2031 |
6.2.5 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Inflammatory Disease, 2021 - 2031 |
6.2.6 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Respiratory Disease, 2021 - 2031 |
6.2.7 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Hospital Associated Infections, 2021 - 2031 |
6.2.8 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Sexual Health Disorders, 2021 - 2031 |
6.3 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Healthcare Centers, 2021 - 2031 |
6.3.4 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Laboratories, 2021 - 2031 |
6.3.5 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Independent Diagnostic Centers, 2021 - 2031 |
6.3.6 Global Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Home Care Settings, 2021 - 2031 |
7 North America Point of Care Infectious Disease Diagnostics Market, Overview & Analysis |
7.1 North America Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
7.2 North America Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.4 North America Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Latin America (LATAM) Point of Care Infectious Disease Diagnostics Market, Overview & Analysis |
8.1 Latin America (LATAM) Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
8.4 Latin America (LATAM) Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
9 Asia Point of Care Infectious Disease Diagnostics Market, Overview & Analysis |
9.1 Asia Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
9.4 Asia Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
10 Africa Point of Care Infectious Disease Diagnostics Market, Overview & Analysis |
10.1 Africa Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
10.4 Africa Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
11 Europe Point of Care Infectious Disease Diagnostics Market, Overview & Analysis |
11.1 Europe Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
11.4 Europe Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
12 Middle East Point of Care Infectious Disease Diagnostics Market, Overview & Analysis |
12.1 Middle East Point of Care Infectious Disease Diagnostics Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Technology, 2021 - 2031 |
12.4 Middle East Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Point of Care Infectious Disease Diagnostics Market, Revenues & Volume, By End User, 2021 - 2031 |
13 Global Point of Care Infectious Disease Diagnostics Market Key Performance Indicators |
14 Global Point of Care Infectious Disease Diagnostics Market - Export/Import By Countries Assessment |
15 Global Point of Care Infectious Disease Diagnostics Market - Opportunity Assessment |
15.1 Global Point of Care Infectious Disease Diagnostics Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Point of Care Infectious Disease Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
15.3 Global Point of Care Infectious Disease Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Point of Care Infectious Disease Diagnostics Market Opportunity Assessment, By End User, 2021 & 2031F |
16 Global Point of Care Infectious Disease Diagnostics Market - Competitive Landscape |
16.1 Global Point of Care Infectious Disease Diagnostics Market Revenue Share, By Companies, 2024 |
16.2 Global Point of Care Infectious Disease Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |